The French Food Safety Agency (AFSSA) suspends the use of diabetes medications Actos and Competact after a study found that they may increase the risk of bladder cancer, with previous research also showing that Actos significantly increased the risk of heart attack.

http://www.bloomberg.com/news/2011-06-09/takeda-s-actos-drug-suspended-in-france-on-cancer-risk-study-3-.html,
http://online.wsj.com/article/BT-CO-20110609-715920.html,
http://www.reuters.com/article/2011/06/10/takeda-europe-japan-idUSL3E7HA06M20110610